Patents Assigned to OptiScan Biomedical Corporation
-
Patent number: 7388202Abstract: A method and apparatus are described that permit an analyte concentration to be estimated from a measurement in the presence of compounds that interfere with the measurement. The method reduces the error in the analyte concentration in the presence of interferents. The method includes the use of a set of measurements obtained for a large population having a range of known analyte and interfering compound concentrations. From a sample measurement, which may or may not be one of the population, likely present interferents are identified, and a calibration vector is calculated.Type: GrantFiled: October 21, 2005Date of Patent: June 17, 2008Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, W. Dale Hall, Kenneth G. Witte, Mark Wechsler, Peng Zheng, Richard Keenan
-
Publication number: 20080072663Abstract: A method of extracting and analyzing bodily fluids from a patient at the point of care for the patient is provided. The method comprises establishing fluid communication between an analyte detection system and a bodily fluid in the patient. A portion of the bodily fluid is drawn from the patient. A first component of the bodily fluid is separated from the drawn portion, while the analyte detection system remains in fluid communication with the patient. The analyte detection system analyzes the first component to measure a concentration of an analyte in an accurate and timely manner.Type: ApplicationFiled: August 15, 2007Publication date: March 27, 2008Applicant: OptiScan Biomedical CorporationInventors: Richard Keenan, Jeffrey Chiou, Roger Tong, Michael Recknor, Ken Li, James Braig, David Callicoat, Jennifer Gable
-
Publication number: 20070278384Abstract: A method and apparatus are described for driving a modulated radiation source (which can be, for example, an infrared light source). The method affects the power driving a light source in such as way so as to minimize the warm-up time of the source. The apparatus permits feedback control of a light source to specified powers or temperatures. Disclosed embodiments can improve source performance and lifetime and decrease the operating costs of the source.Type: ApplicationFiled: May 31, 2007Publication date: December 6, 2007Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventor: Kevin Heppell
-
Publication number: 20070258083Abstract: Methods and apparatus are provided for determining the concentration of an analyte in a sample, such as an analyte in a sample of bodily fluid. Some embodiments use a synchronous demodulator and digital filter to reduce microphonic signal content. Some embodiments monitor the microphonic signal content and “hold off” on making a measurement until vibrations subside. Monitoring can be performed using an accelerometer or other vibration sensor. An algorithm can be used to examine the detector output signal and detect excessive microphonic components, making an accelerometer unnecessary.Type: ApplicationFiled: April 11, 2007Publication date: November 8, 2007Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: Kevin Heppell, James Braig
-
Publication number: 20070239096Abstract: Methods and apparatus are provided for determining the concentration of an analyte in a sample, such as an analyte in a sample of bodily fluid. In some embodiments, a method for maintaining clear passageways in an extracorporeal blood flow system includes intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. In some embodiments, an extracorporeal blood flow system includes a passageway and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.Type: ApplicationFiled: April 11, 2007Publication date: October 11, 2007Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: Richard Keenan, Jeff Chiou
-
Patent number: 7271912Abstract: A method determines an analyte concentration in a sample. The sample includes the analyte and a substance. The method includes providing absorption data of the sample. The method further includes providing reference absorption data of the substance. The method further includes calculating a substance contribution of the absorption data. The method further includes subtracting the substance contribution from the absorption data, thereby providing corrected absorption data substantially free of a contribution from the substance.Type: GrantFiled: April 15, 2004Date of Patent: September 18, 2007Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Philip C. Hartstein, Robert D. Gaffney
-
Publication number: 20070083143Abstract: A method for maintaining clear passageways in an extracorporeal blood flow system. The method comprises intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. Also disclosed is an extracorporeal blood flow system. The system comprises a passageway, and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.Type: ApplicationFiled: December 21, 2005Publication date: April 12, 2007Applicant: OptiScan Biomedical CorporationInventors: James Braig, Richard Keenan
-
Patent number: 7096124Abstract: A method determines an analyte concentration in a sample including the analyte and a substance. The method includes providing an absorption spectrum of the sample. The absorption spectrum has an absorption baseline. The method further includes shifting the absorption spectrum so that the absorption baseline approximately equals a selected absorption value in a selected absorption wavelength range. The method further includes subtracting a substance contribution from the absorption spectrum. Thus, the method provides a corrected absorption spectrum substantially free of a contribution from the substance.Type: GrantFiled: February 18, 2005Date of Patent: August 22, 2006Assignee: Optiscan Biomedical CorporationInventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Kenneth G. Witte
-
Patent number: 7006857Abstract: A method of determining the analyte concentration of a test sample is described. A temperature gradient is introduced in the test sample and infrared radiation detectors measure radiation at selected analyte absorbance peak and reference wavelengths. Reference and analytical signals are detected. In the presence of the selected analyte, parameter differences between reference and analytical signals are detectable. These parameter differences, having a relationship to analyte concentration, are measured, correlated, and processed to determine analyte concentration in the test sample. Accuracy is enhanced by inducing a periodically modulated temperature gradient in the test sample. The analytical and reference signals may be measured continuously and the parameter difference integrated over the measurement period to determine analyte concentration.Type: GrantFiled: April 28, 2003Date of Patent: February 28, 2006Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Charles E. Kramer, Bernhard B. Sterling, Daniel S. Goldberger, Peng Zheng, Arthur M. Shulenberger, Rick Trebino, Richard A. King, Casper W. Barnes
-
Patent number: 6989891Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.Type: GrantFiled: August 14, 2002Date of Patent: January 24, 2006Assignee: Optiscan Biomedical CorporationInventors: James R. Braig, Peter Rule, Philip C. Hartstein
-
Patent number: 6983177Abstract: A spectroscopic sample holder comprises a microporous sheet. The microporous sheet has a top surface, a bottom surface substantially parallel to the top surface, and at least one side surface oriented substantially perpendicular to the top and bottom surfaces. The side surface forms an exposed transit opening configured to contact a material sample and distribute the contacted material sample into the microporous sheet. The spectroscopic sample holder further comprises a first planar support member positioned on, and substantially parallel to, the top surface of the microporous sheet. The spectroscopic sample holder further comprises a second planar support member positioned on the bottom surface of the microporous sheet, and oriented substantially parallel to the first planar support member.Type: GrantFiled: January 6, 2003Date of Patent: January 3, 2006Assignee: Optiscan Biomedical CorporationInventors: Peter Rule, James R. Braig, Philip C. Hartstein
-
Patent number: 6958809Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.Type: GrantFiled: January 21, 2002Date of Patent: October 25, 2005Assignee: Optiscan Biomedical CorporationInventors: Bernhard B. Sterling, Philip C. Hartstein, Ken I. Li, Mark D. Agostino, David C. Klonoff, Robert D. Gaffney, Jennifer H. Gable, Ken G. Witte, Mike A. Munrow, Daniel S. Goldberger, Julian M. Cortella, James R. Braig, Peter Rule
-
Patent number: 6944486Abstract: A method and apparatus of determining the analyte concentration of a test sample is described. A temperature gradient is introduced into the test sample and infrared radiation detectors measure radiation at selected analyte absorbance peak and reference wavelengths. The modulation of the temperature gradient is controlled by a surface temperature modulation. A transfer function is determined that relates the surface temperature modulation to the modulation of the measured infrared radiation. Reference and analytical signals are detected. In the presence of the selected analyte, phase and magnitude differences in the transfer function are detected. These phase and magnitude differences, having a relationship to analyte concentration, are measured, correlated and processed to determine analyte concentration in the sample.Type: GrantFiled: June 6, 2003Date of Patent: September 13, 2005Assignee: Optiscan Biomedical CorporationInventors: James R. Braig, Charles E. Kramer, Bernhard B. Sterling, Daniel S. Goldberger, Peng Zheng, Arthur M. Shulenberger, Rick Trembino, Richard A. King, Casper W. Barnes
-
Patent number: 6917038Abstract: An analyte detection system non-invasively determines the concentration of an analyte in a sample generating a sample infrared signal indicative of the concentration of the analyte in the sample. The detection system includes a window assembly for receiving the sample infrared signal. The window assembly is adapted to allow the sample infrared signal to transmit therethrough, and generates a window infrared signal. The detection system further includes at least one detector configured to receive both the window infrared signal and the sample infrared signal transmitted through the window assembly. The detector is further adapted to generate a detector signal in response thereto. The detection system further includes a correction module configured to generate a corrected detector signal indicative of the concentration of the analyte in the sample.Type: GrantFiled: November 21, 2002Date of Patent: July 12, 2005Assignee: Optiscan Biomedical CorporationInventors: Peng Zheng, Jennifer H. Gable, W. Dale Hall, Kenneth G. Witte, James R. Braig
-
Patent number: 6862534Abstract: A method determines an analyte concentration in a sample including the analyte and a substance. The method includes providing an absorption spectrum of the sample. The absorption spectrum has an absorption baseline. The method further includes shifting the absorption spectrum so that the absorption baseline approximately equals a selected absorption value in a selected absorption wavelength range. The method further includes subtracting a substance contribution from the absorption spectrum. Thus, the method provides a corrected absorption spectrum substantially free of a contribution from the substance.Type: GrantFiled: February 12, 2003Date of Patent: March 1, 2005Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Philip C. Hartstein, Robert D. Gaffney
-
Patent number: 6825044Abstract: A device and method for determining analyte concentrations within a material sample are provided. A modulating temperature gradient is induced in the sample and resultant, emitted infrared radiation is measured at selected analyte absorbance peaks and reference wavelengths. The modulating temperature gradient is controlled by a surface temperature modulation. A transfer function relating the surface temperature modulation to a modulation of the measured infrared radiation is provided. Phase and magnitude differences in the transfer function are detected. These phase and magnitude differences, having a relationship to analyte concentration, are measured, correlated and processed to determine analyte concentration in the material sample. A method for adjusting an analyte measurement is provided. The method provides a hydration correction process for calibration and correction whereby analyte concentrations within the material sample may be determined.Type: GrantFiled: November 21, 2002Date of Patent: November 30, 2004Assignee: Optiscan Biomedical CorporationInventors: Peng Zheng, Jennifer H. Gable, W. Dale Hall, Kenneth G. Witte, James R. Braig
-
Patent number: 6771993Abstract: An adapter presents a sample of bodily fluid, such as whole blood, including an analyte to an analyzer window of a non-invasive monitor. The adapter comprises a base material that comprises a first side and a second side. The adapter also comprises a sample accommodating volume extending between an opening in the second side of the base material and an opening in the first side of the base material.Type: GrantFiled: August 15, 2002Date of Patent: August 3, 2004Assignee: OptiScan Biomedical CorporationInventors: Peter Rule, James R. Braig, Philip C. Hartstein, Jennifer H. Gable
-
Patent number: 6645142Abstract: A glucose monitoring instrument having network-based communication features which provide a link between patient and practitioner. The glucose monitoring instrument comprises circuitry for communicating data with one or more destination sites on the network which are configured to transmit and receive information to and from the instrument. Instrument measurements are transmitted over the link in addition to information and guidance, to provide increased accuracy, improved program compliance, and patient guidance from a supervisory authority or medical practitioner. In addition, a set of calibration features encourage calibration compliance.Type: GrantFiled: December 1, 2000Date of Patent: November 11, 2003Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Gary E. Hewett, Michael A. Munrow, Julian M. Cortella, Kamrava Azizi, Daniel S. Goldberger
-
Patent number: 6636753Abstract: A solid-state spectrometer for the non-invasive generation and capture of thermal gradient spectra from human or animal tissue. The spectrometer includes an infrared transmissive thermal mass window for inducing a transient temperature gradient in the tissue by means of conductive heat transfer with the tissue, and cooling means in operative combination with the thermal mass window for cooling the thermal mass window. Also provided is an infrared sensor means for detecting infrared emissions emanating from the tissue as the transient temperature gradient progresses into the tissue, and for providing output signals proportional to the detected infrared emissions. Data capture means is provided for sampling the output signals received from the infrared sensor means as the transient temperature gradient progresses into the tissue.Type: GrantFiled: January 11, 2001Date of Patent: October 21, 2003Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Bernhard B. Sterling, Daniel S. Goldberger, Joan C. Godfrey, Julian Cortella, David J. Correia, Arthur M. Shulenberger, Charles E. Kramer
-
Patent number: 6633771Abstract: A solid-state device for the non-invasive generation and capture of thermal gradient spectra from sample tissue. The device includes an infrared transmissive layered window assembly, a means for inducing a thermal gradient in sample tissues. Also provided is an infrared radiation detector for detecting infrared emissions emanating from the tissue as the transient temperature gradient progresses into the sample tissues. The sensor provides output signals proportional to the detected infrared emissions. A data capture means is provided for the sampling of output signals received from the infrared radiation detector as the induced temperature gradient progresses into the sample tissue.Type: GrantFiled: October 25, 1999Date of Patent: October 14, 2003Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Bernhard B. Sterling, Joan C. Godfrey, Julian M. Cortella, David J. Correia, Charles E. Kramer, Arthur M. Shulenberger